High Court's Sorrell Ruling Yet To Transform Drug Marketing
The U.S. Supreme Court's 2011 ruling in Sorrell v. IMS Health set the stage for looser limits on off-label promotion by drugmakers, but experts say the upshot for Big Pharma has...To view the full article, register now.
Already a subscriber? Click here to view full article